Conformationally constrained analogues of bleomycin A5

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Drug Discovery

Background:

• Bleomycin (BLM) antibiotics are natural products that induce DNA damage.
• The linker region of BLM, containing methylvalerate and threonine, is crucial for DNA cleavage.
• Conformational flexibility of the valerate moiety may influence BLM's DNA interaction.

Purpose of the Study:

• To synthesize and evaluate conformationally constrained methylvalerate analogues of deglycobleomycin A(5).
• To investigate the role of conformational constraint in the valerate linker on DNA and RNA cleavage activity.
• To assess the oxygen transfer capabilities of these novel BLM analogues.

Main Methods:

• Solid-phase synthesis of deglycobleomycin A(5) congeners with constrained methylvalerate analogues.
• Assay of DNA cleavage activity and sequence selectivity.
• Assessment of alkali-labile lesion formation and RNA cleavage.
• Evaluation of oxygenation of small molecules.

Main Results:

• Synthesized analogues exhibited DNA cleavage activity but lacked sequence selectivity and were less potent than (deglyco)BLM.
• Analogues did not produce alkali-labile DNA lesions or sequence-selective RNA oxidative damage.
• Two analogues mediated RNA cleavage independently of Fe(2+).
• Constrained analogues efficiently transferred oxygen to small molecules, comparable to the parent compound.

Conclusions:

• Conformational constraint in the methylvalerate linker affects BLM's DNA cleavage properties, reducing potency and selectivity.
• Novel RNA cleavage activity was observed for some analogues, suggesting potential for new therapeutic mechanisms.
• The oxygen transfer capability of the analogues remains intact, indicating preserved functionality in other aspects.